Cargando…

Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min

Edoxaban 60 mg is approved for stroke prevention in patients with atrial fibrillation (AF) not fulfilling any dose‐reduction criteria. As edoxaban is partially renally cleared (≈50%), this study compared pharmacokinetics (PK) and pharmacodynamics of edoxaban 60 mg once daily with edoxaban 75 mg once...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Ophelia, Kakkar, Tarundeep, Duggal, Anil, Kotsuma, Masakatsu, Shi, Minggao, Lanz, Hans, Grosso, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299591/ https://www.ncbi.nlm.nih.gov/pubmed/34877813 http://dx.doi.org/10.1002/cpdd.1050

Ejemplares similares

An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy Adults
por: Duchin, Kenneth, et al.
Publicado: (2017)

Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
por: van Ommen, Cornelia Heleen, et al.
Publicado: (2020)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min
por: Ross, Lisa L., et al.
Publicado: (2019)

Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine
por: Parasrampuria, Dolly A., et al.
Publicado: (2016)

Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine
por: Wang, Sheng, et al.
Publicado: (2021)

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
por: Ansell, Jack E., et al.
Publicado: (2017)

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
por: Zelniker, Thomas A., et al.
Publicado: (2021)

Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
por: Bosch, Floris T. M., et al.
Publicado: (2021)

Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery
por: Walter, Jörg, et al.
Publicado: (2003)

History of creatinine clearance: tribute to a forerunner
por: Losito, Attilio
Publicado: (2023)

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
por: Fanola, Christina L., et al.
Publicado: (2018)

Estimating Creatinine Clearance in the Nonsteady State: The Determination and Role of the True Average Creatinine Concentration
por: Chen, Sheldon, et al.
Publicado: (2019)

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
por: Xu, Haiyan, et al.
Publicado: (2016)

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
por: Kato, Eri Toda, et al.
Publicado: (2016)

Relationship between creatinine clearance and clinical outcomes in Chinese emergency patients with atrial fibrillation
por: Wang, Juan, et al.
Publicado: (2022)

Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study
por: Minville, Vincent, et al.
Publicado: (2011)

Performance of creatinine-based equations for estimating glomerular filtration rate compared to endogenous creatinine clearance
por: da Fonseca, Gisele da Silva, et al.
Publicado: (2021)

Discordance of renal drug dosing using estimated creatinine clearance and measured urine creatinine clearance in hospitalized adults: A retrospective cohort study
por: Brown, Austin R., et al.
Publicado: (2020)

Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
por: Bavalia, Roisin, et al.
Publicado: (2021)

Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism
por: Vandell, Alexander G, et al.
Publicado: (2017)

The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
por: Siriez, Romain, et al.
Publicado: (2022)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
por: Vio, Riccardo, et al.
Publicado: (2021)

Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients.
por: Lindegaard, M. W., et al.
Publicado: (1991)

292 Augmented Renal Clearance in Burn Patients: Incidence and Discordance with Standard Creatinine Clearance Estimation
por: Mueller, Scott W, et al.
Publicado: (2023)

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations
por: Levin, Mark-David, et al.
Publicado: (2020)

The predictive value of creatinine clearance for mortality in patients undergoing revascularization
por: Ram, Eilon, et al.
Publicado: (2021)

Average creatinine–urea clearance: revival of an old analytical technique?
por: Selistre, Luciano, et al.
Publicado: (2023)

Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
por: Lin, Shin-Yi, et al.
Publicado: (2021)

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
por: Mendell, Jeanne, et al.
Publicado: (2013)

Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients
por: Pickering, John W, et al.
Publicado: (2012)

Carrier multiplication in perovskite solar cells with internal quantum efficiency exceeding 100%
por: Wang, Yue, et al.
Publicado: (2023)

Efficient ReML inference in variance component mixed models using a Min-Max algorithm
por: Laporte, Fabien, et al.
Publicado: (2022)

Comparison of Jaffe Method and Enzymatic Method at Measuring Serum Creatinine Level, Creatinine Clearance and Estimated Glomerular Filtration Rate
por: Osmic–Husni, Alma, et al.
Publicado: (2023)

Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
por: Ando, Y., et al.
Publicado: (1997)

Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance
por: Chowta, N. K., et al.
Publicado: (2009)

Cimetidine Improves the Accuracy of Creatinine Clearance as an Indicator for Glomerular Filtration Rate
por: Choi, Ki Chul, et al.
Publicado: (1993)

The Effect of Cadmium on GFR Is Clarified by Normalization of Excretion Rates to Creatinine Clearance
por: Satarug, Soisungwan, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects
por: Parasrampuria, Dolly A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l0sschl5utatbbcai9ut1dobef